244 - 5 Critical Quality Differences Between Drugs and Devices

<p><strong>Download the free Drug vs. Device Quality comparison guide here:</strong><a href="https://letscombinate.kit.com/216fbfc6c2" target="_new" rel="noopener"> https://letscombinate.kit.com/216fbfc6c2</a></p><p><br></p><p>In this Let’s Combinate episode, Subhi explains why drug and device quality are not the same and highlights five key areas where they differ for combination products.</p><p><br></p><p>Drug quality often focuses on consistently remaking the product that was proven clinically, using critical quality attributes, specifications, analytical methods, stability, process validation, and batch release.</p><p><br></p><p>Device quality emphasizes design robustness and intended use through design controls and product realization, from user needs and design inputs to validation and design transfer.</p><p><br></p><p>This episode covers five major differences:</p><p>Quality philosophy and evidence</p><p>Development approach</p><p>Risk management</p><p>Regulatory submission focus</p><p>Lifecycle management and change control</p><p><br></p><p>The goal is not to force one system onto the other. The goal is to understand the differences early enough to intentionally integrate drug and device quality across development, manufacturing, regulatory strategy, and lifecycle management.</p><p><br></p><p>Chapters</p><p><br></p><p>00:00 Drugs vs. Devices: Why Quality Differs</p><p>00:20 Intro and Practical Guide</p><p>00:50 Quality Philosophy and Evidence</p><p>02:27 Development Approach Differences</p><p>03:56 Risk Management Mindsets</p><p>05:48 Regulatory Submission Focus</p><p>06:23 Lifecycle and Change Control</p><p>08:03 Summary and Next Steps</p><p><br></p><p>Subhi Saadeh is a quality professional, consultant, auditor, and trainer who specializes in drug-device combination products, medical devices, pharmaceutical quality systems, supplier quality, and lifecycle management. Through Let’s Combinate, he helps pharmaceutical and medical device teams bridge the gap between drug and device quality, regulatory expectations, and practical execution.</p>